日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Overexpressed kinetochore genes are used by cancer cells as genome destabilizers and transformation catalysts

过度表达的动粒基因被癌细胞用作基因组不稳定剂和转化催化剂

Reem Kamal Aldwaik, Denen Shian, Roshina Thapa, Swetha Vasudevan, Mimi Abo-Ayoub Ashqar, Eli Reich, Nataly Kravchenko-Balasha, Michael Klutstein

Overcoming resistance to EGFR monotherapy in HNSCC by identification and inhibition of individualized cancer processes

通过识别和抑制个性化癌症过程克服 HNSCC 对 EGFR 单药治疗的耐药性

Maria R Jubran, Daniela Vilenski, Efrat Flashner-Abramson, Efraim Shnaider, Swetha Vasudevan, Ariel M Rubinstein, Amichay Meirovitz, Shay Sharon, David Polak, Nataly Kravchenko-Balasha

Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance

计算量化和表征肿瘤内独立进化的细胞亚群对于抑制抗癌治疗耐药性至关重要

Heba Alkhatib #, Ariel M Rubinstein #, Swetha Vasudevan, Efrat Flashner-Abramson, Shira Stefansky, Sangita Roy Chowdhury, Solomon Oguche, Tamar Peretz-Yablonsky, Avital Granit, Zvi Granot, Ittai Ben-Porath, Kim Sheva, Jon Feldman, Noa E Cohen, Amichay Meirovitz #, Nataly Kravchenko-Balasha #

Explant Modeling of the Immune Environment of Head and Neck Cancer

头颈癌免疫环境的外植体建模

Shay Sharon, Thomas Duhen, Shelly Bambina, Jason Baird, Rom Leidner, Bryan Bell, Nardy Casap, Marka Crittenden, Swetha Vasudevan, Maria Jubran, Nataly Kravchenko-Balasha, Michael Gough

Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures

可通过解析和靶向个性化信号特征来控制三阴性乳腺癌中药物诱导的耐药性和表型转变

Swetha Vasudevan, Ibukun A Adejumobi, Heba Alkhatib, Sangita Roy Chowdhury, Shira Stefansky, Ariel M Rubinstein, Nataly Kravchenko-Balasha